OLEMA PHARMACEUTICALS, INC. Capital Expenditures Incurred but Not yet Paid
OLEMA PHARMACEUTICALS, INC. (OLMA) reported Capital Expenditures Incurred but Not yet Paid of $94.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2022-11-08
- OLEMA PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2021-09-30 was $51.00K.
- OLEMA PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2021-06-30 was $24.00K.
- OLEMA PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2021-03-31 was $39.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month |
|---|---|---|---|
| 2022-06-30 | $94.00K 10-Q · filed 2022-08-09 | ||
| 2021-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $75.00K derived: sum of 2 quarters · filed 2022-11-08 | $114.00K 10-Q · filed 2022-11-08 |
| 2021-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $63.00K 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $39.00K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |